Skip to main content

Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.

Publication ,  Journal Article
Lyman, GH; Moses, HL
Published in: N Engl J Med
July 7, 2016

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

July 7, 2016

Volume

375

Issue

1

Start / End Page

4 / 6

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States Dept. of Health and Human Services
  • United States
  • Research Support as Topic
  • Precision Medicine
  • National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division
  • Humans
  • Health Policy
  • Genomics
  • General & Internal Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., & Moses, H. L. (2016). Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine. N Engl J Med, 375(1), 4–6. https://doi.org/10.1056/NEJMp1604033
Lyman, Gary H., and Harold L. Moses. “Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.N Engl J Med 375, no. 1 (July 7, 2016): 4–6. https://doi.org/10.1056/NEJMp1604033.
Lyman, Gary H., and Harold L. Moses. “Biomarker Tests for Molecularly Targeted Therapies--The Key to Unlocking Precision Medicine.N Engl J Med, vol. 375, no. 1, July 2016, pp. 4–6. Pubmed, doi:10.1056/NEJMp1604033.

Published In

N Engl J Med

DOI

EISSN

1533-4406

Publication Date

July 7, 2016

Volume

375

Issue

1

Start / End Page

4 / 6

Location

United States

Related Subject Headings

  • United States Food and Drug Administration
  • United States Dept. of Health and Human Services
  • United States
  • Research Support as Topic
  • Precision Medicine
  • National Academies of Science, Engineering, and Medicine, U.S., Health and Medicine Division
  • Humans
  • Health Policy
  • Genomics
  • General & Internal Medicine